Note that some links may require registration or subscription.
The government’s switch in how COVID-19 data are collected and publicly reported “has been a disaster.” (Wall Street Journal)
The White House released guidelines for reopening K-12 schools, which included required “self-health assessments” and “encouraging” use of masks.
Russia dug its heels in on the rapid approval of its “Sputnik V” vaccine and announced that the first batch will be rolled out in two weeks, with mass vaccination to start in October, even as Western experts expressed worry about the risks. (Reuters, CNBC)
As of 8:00 a.m. ET Thursday, the unofficial U.S. tally reached 5,197,749 cases and 166,038 deaths — up 55,870 and 1,493, respectively, from this time a day ago. That daily deaths figure is the highest in more than 2 months.
New Jersey schools from pre-K to universities may reopen for in-person instruction starting this fall, said Governor Phil Murphy. (Reuters)
Just 8 days after reopening schools without mask requirements, a Georgia school district closed a high school after finding at least a dozen confirmed coronavirus cases between students and staff.
TV doctor Sanjay Gupta, MD, explains why he won’t let his three girls go back to school next week. (CNN)
Infected healthcare workers lament the pressure to go back to work at hospitals and clinics. (Kaiser Health News)
Meanwhile, newspaper reporters mourn another casualty of the pandemic — their newsrooms, some of which will be closed permanently. (CNN)
A Florida sheriff prohibited deputies from wearing masks on duty except when working by a hospital or dealing with people suspected of being infected. (Washington Post)
France reports a new but manageable spike in COVID-19 infections while hospitalizations continue to decrease. (Reuters)
Hospitals and physician offices are among the many employers that will have to figure out how to respond to President Trump’s temporary order for payroll tax suspension. (NPR)
Big antibody testing program in Britain suggests about 3.5 million people (6% of the population) have been infected — thus falling far short of levels needed for herd immunity. (Imperial College London)
Updated phase I/II results with Pfizer’s and BioNTech’s RNA vaccine were published Wednesday in Nature.
In other news:
- FDA added compliance requirements for manufacturers wishing to label foods as “gluten-free”.
- A third treatment for Duchenne muscular dystrophy is approved — but do any of them actually work? (Endpoints News)
- Thermo Fisher’s deal to acquire diagnostic testing leader Qiagen is off. (Reuters)
- The Beirut explosion left many children in Lebanon without access to cancer chemotherapy. (New York Times)